date,title,source
Oct-29-18,ProQR In-licenses Worldwide Rights to Ophthalmology Drug Candidate from Ionis Pharmaceuticals,GlobeNewswire
Oct-31-18,ProQR Announces Presentations at the European Oligonucleotide and Peptide Therapeutics Conference,GlobeNewswire
Nov-07-18,"ProQR (PRQR) Reports Q3 Loss, Misses Revenue Estimates",Zacks
Nov-07-18,ProQR: 3Q Earnings Snapshot,Associated Press
Nov-07-18,ProQR Announces Financial Results for the Third Quarter of 2018,GlobeNewswire
Nov-16-18,"Consolidated Research: 2018 Summary Expectations for ProQR Therapeutics N.V, Biomerica, VEREIT, Apergy, Zendesk, and Arcus Biosciences  Fundamental Analysis, Key Performance Indications",GlobeNewswire
Nov-20-18,ProQR to Present at the Evercore ISI HealthConX Conference,GlobeNewswire
Dec-04-18,ProQR Announces Clearance of IND to Start Clinical Trial of QR-421a in Usher Syndrome Type 2 Patients,GlobeNewswire
